Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin-Reference-Cited by-同舟云学术

Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin

Published:2014-09 Issue:9 Volume:20 Page:1399-1406
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Capelli Debora,Chiarucci Martina,Poloni Antonella,Saraceni Francesco,Mancini Giorgia,Trappolini Silvia,Troiani Emanuela,Montanari Mauro,Scortechini Ilaria,Offidani Massimo^ORCID,Rupoli Serena,Scortechini Anna Rita,Gini Guido,Discepoli Giancarlo,Leoni Pietro,Olivieri Attilio

Funder

Associazione Italiana contro le Leucemie-Linfomi e Mieloma (AIL)

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference42 articles.

1. Cytogenetics and age are the major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from the AMLSG trial AML HD98-B;Fröhling;Blood,2006

2. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from cancer and leukemia group B 8461. Cancer and Leukemia Group B 8461;Farag;Blood,2006

3. Treatment of acute myeloid leukemia: are we making progress?;Burnett;Hematology Am Soc Hematol Educ Program,2012

4. High-dose daunorubicin in older patients with acute myeloid leukemia;Löwenberg;N Engl J Med,2009

5. Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia;Kantarjian;Blood,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Auto-hematopoietic stem cell transplantation or chemotherapy? Meta-analysis of clinical choice for AML;Annals of Hematology;2024-01-25

2. Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients;Annals of Hematology;2023-02-16

3. Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experience and current challenges;International Journal of Hematology;2022-05-13

4. Clinical Benefits and Safety of Gemtuzumab Ozogamicin in Treating Acute Myeloid Leukemia in Various Subgroups: An Updated Systematic Review, Meta-Analysis, and Network Meta-Analysis;Frontiers in Immunology;2021-08-16

5. Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults;Expert Opinion on Biological Therapy;2020-10-05